Table 2.
Polyphenols intake among women diagnosed with breast cancer measured at baseline, total and by country.
| All (n=11,782) | France (n=3,256) |
Italy (n=1,062) |
Spain (n=507) |
UK GP (n=484) |
UK HC (n=1019) |
NL (n=931) |
Greece (n=201) |
Germany (n=852) |
Sweden (n=1,117) |
Denmark (n=1,354) |
Norway (n=999) |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total polyphenol intake | 1121 (439;2226) |
1332 (562;2549) |
1075 (434;1426) |
690 (266;1400) |
1523 (778;2367) |
1441 (650;2303) |
1158 (655–1789) |
790 (326;1492) |
1056 (530;1907) |
826 (404;1558) |
1560 (818; 2485) |
646 (246;1093) |
| Flavonoids | 444 (120–1260) |
530 (189–1240) |
415 (166–806) |
292 (82–657) |
935 (359–1512) |
864 (323–1533) |
511 (177–1003) |
266 (102–556) |
427 (149–1054) |
260 (84–646) |
527 (142–1433) |
179 (62–397) |
| Phenolic acids | 539 (141–1408) |
677 (167–1806) |
380 (120–754) |
319 (67–854) |
363 (188–1068) |
507 (129–1061) |
584 (252–950) |
432 (106–1049) |
497 (190–1070) |
483 (165–1054) |
880 (305–1545) |
365 (65–856) |
| Stilbenes | 0.6 (0.0–8.1) |
1.3 (0.1 9.8) |
0.4 (0.0–8.6) |
0.1 (0.0–5.9) |
0.0 (0.0–2.9) |
0.4 (0.0–6.6) |
0.2 (0.0–3.8) |
0.2 (0.0–2.4) |
0.8 (0.1–5.9) |
0.3 (0.0–2.9) |
1.5 (0.1–8.5) |
0.5 (0.0–2.8) |
| Lignans | 1.4 (0.7–4.6) |
1.6 (1–4) |
3.3 (1.4–11.9) |
1.5 (0.8–2.9) |
1.6 (0.8–3.0) |
1.7 (0.9–3.0) |
0.9 (0.7–1.7) |
2.2 (1.2–11.0) |
1.2 (0.7–5.4) |
1.1 (0.6–2.3) |
1.4 (0.7–3.0) |
1.0 (0.5–1.9) |
| Other polyphenols | 38 (12–97) |
25 (8–63) |
35 (18–71) |
28 (11– 83) |
36 (8–109) |
36 (10–99) |
41 (17–68) |
65 (36–122) |
62 (25–119) |
42 (20–88) |
69 (30–121) |
40 (15–65) |
All values are in mg/day and are presented as medians (P5–P95)
UK GP– United Kingdom cohort representing general population
UK HC– United Kingdom health conscious cohort
NL: The Netherlands
P5– 5th percentile, P95– 95th percentile